SCHEMBL28919623

SCHEMBL28919623

Oc1cnncc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31652063 0.75
SCHEMBL9666642 0.70 ALDH1A1 (0.43)
SCHEMBL22283932 0.70 IDO1 (0.47)
SCHEMBL3523197 0.69 ALDH1A1 (0.42)
Bromide SCHEMBL9548958 0.68 ALDH1A1 (0.42)
SCHEMBL29846477 0.60 CDC25B (0.30)
SCHEMBL30574445 0.60 CDC25B (0.30)
SCHEMBL1324800 0.60 ALDH1A1 (0.42)
SCHEMBL31005906 0.60
SCHEMBL13360292 0.60 HSD17B1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113698355-B Synthesis method of 4, 5-dihydroxypyridazine 郑州华赞医药科技有限公司 2023-05-26 CN claimed
CN-113698355-A Synthesis method of 4, 5-dihydroxypyridazine 郑州华赞医药科技有限公司 2021-11-26 CN claimed
CN-113698355-B Synthesis method of 4, 5-dihydroxypyridazine 郑州华赞医药科技有限公司 2023-05-26 CN disclosed
CN-113698355-B Synthesis method of 4, 5-dihydroxypyridazine 郑州华赞医药科技有限公司 2023-05-26 CN disclosed
CN-113698355-B Synthesis method of 4, 5-dihydroxypyridazine 郑州华赞医药科技有限公司 2023-05-26 CN disclosed
CN-113698355-A Synthesis method of 4, 5-dihydroxypyridazine 郑州华赞医药科技有限公司 2021-11-26 CN disclosed
CN-113698355-A Synthesis method of 4, 5-dihydroxypyridazine 郑州华赞医药科技有限公司 2021-11-26 CN disclosed
CN-113698355-A Synthesis method of 4, 5-dihydroxypyridazine 郑州华赞医药科技有限公司 2021-11-26 CN disclosed
CN-112978709-A Carbon quantum dot precursor composition, carbon quantum dot and preparation method thereof 中国科学院大连化学物理研究所 2021-06-18 CN disclosed